L I S T O F TA B L E S , F I G U R E S A N D E X E M P L A R S ( C O N T ’ D ) Figure 12: Engagement Activities......................................................................................................................................................33 Figure 13: Presentations Made at Scientific Meetings........................................................................................................................34 Figure 14: Geographic Reach of Engagement Activities..................................................................................................................... 35 Figure 15: Audiences Reached Through Engagement Activities......................................................................................................... 35 Figure 16: Main Purposes of Engagement Activities and Audience Size............................................................................................. 36 Figure 17: Most Important Impacts of Engagement Activities........................................................................................................... 37 Figure 18: Influences on Policy, Practice, Patients and the Public....................................................................................................... 45 Figure 19: Year the Influence on Policy, Practice, Patients and the Public Was First Realized.............................................................. 45 Figure 20: Geographic Reach of Influence on Policy, Practice, Patients and the Public....................................................................... 46 Figure 21: Impacts of Influences on Policy, Practice, Patients and the Public..................................................................................... 47 Figure 22: Distribution of Medical Products, Interventions and Clinical Trials.................................................................................. 48 Figure 23: Development Stages Based on Type of Medical Product & Intervention........................................................................... 50 Figure 24: Moving Along the Pathway to Impact: Early Outcomes.................................................................................................... 56 Figure 25: Distribution of Reported Outcomes: Summary................................................................................................................ 57
Exemplars Exemplar 1: Searching for a new gold standard................................................................................................................................ 18 Exemplar 2: Game-changing treatment............................................................................................................................................ 19 Exemplar 3: Building the tools to fight prostate cancer....................................................................................................................21 Exemplar 4: Opening access to databases to advance research........................................................................................................... 22 Exemplar 5: Culturally appropriate data handling............................................................................................................................ 23 Exemplar 6: Engineering the future of health through collaboration................................................................................................ 29 Exemplar 7: Developing marketable skills for the knowledge-based economy.................................................................................. 29 Exemplar 8: Highlighting the importance of partnering with policy makers..................................................................................... 30 Exemplar 9: Researchers and community: Engaging together to fight cancer.................................................................................... 38 Exemplar 10: Engaging practitioners and patients in using health resources wisely............................................................................. 39 Exemplar 11: More than a drop in the bucket.................................................................................................................................... 40 Exemplar 12: Connecting communities around health issues............................................................................................................. 41 Exemplar 13: Connecting patients and researchers............................................................................................................................. 42 Exemplar 14: Connecting through creativity...................................................................................................................................... 43 Exemplar 15: Ambulosono: Technology to enhance the continuum of rehabilitation care.................................................................. 51 Exemplar 16: Addressing cancer screening in Aboriginal communities............................................................................................... 52 Exemplar 17: Enhancing surgical care to deliver benefits to patients and the health system................................................................ 54 Exemplar 18: Collaborating from ‘door to needle’ to implement new stroke therapy..........................................................................55
ANNUAL IMPACT REPORT 2014-15
iii